KELES
Overview
KELES is a venture capital firm specializing in growth-stage digital health investments across Europe, focusing on AI-powered drug discovery, precision diagnostics, and next-generation digital health solutions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eclevar Medtech | - | VC Round | Co-investor |
Key People
Laurent van Lerberghe
Founder and Managing Partner
Alexandre Z Karkour
Venture Partner
Michal Zurawski
Investment Partner
Pooja M.
Investment Partner
Zak P.
Investment Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is KELES based?
KELES is headquartered in Luxembourg, Luxembourg.
When was KELES founded?
KELES was founded in 2023.
How many portfolio companies does KELES have?
KELES has 1 portfolio company in Caplight's dataset.
What are some companies in KELES's portfolio?
Portfolio companies visible on Caplight include Eclevar Medtech.
What was KELES's most recent investment shown here?
KELES's most recent investment in this portfolio sample was in Eclevar Medtech.
What sectors does KELES focus on?
KELES focuses on Healthcare & Life Sciences.
What company stages does KELES focus on?
Stage focus information for KELES is not publicly available.
What is KELES's AUM?
KELES's assets under management are estimated between $270.0M and $270.0M.